HOME   
   NEWS   
   BUSINESS   
   CRICKET   
   SPORTS   
   MOVIES   
   NET GUIDE   
   SHOPPING   
   BLOGS  
   ASTROLOGY  
   MATCHMAKER  


Search:



The Web

Rediff








Business
Portfolio Tracker
Business News
Specials
Columns
Market Report
Mutual Funds
Interviews
Tutorials
Message Board
Stock Talk



Home > Business > Corporate Headline > Quick Company Info

Risc

Ranbaxy denies receiving notice

February 20, 2003 12:13 IST

Ranbaxy Laboratories Ltd said it has not received any notice from National Pharmaceutical Pricing Authority to deposit Rs 15 million as penalty for pricing flaws.

BSE code: 500359



Article Tools

Email this Article

Printer-Friendly Format

Letter to the Editor



Related Stories


Ranbaxy launches Cefprozil

Ranbaxy unveils pill



People Who Read This Also Read


Cigarette stocks get butted down

Allies flay govt over selloff

BPCL pumped up







HOME   
   NEWS   
   BUSINESS   
   CRICKET   
   SPORTS   
   MOVIES   
   NET GUIDE   
   SHOPPING   
   BLOGS  
   ASTROLOGY  
   MATCHMAKER  
© 2003 rediff.com India Limited. All Rights Reserved.